Investor Says Biotech Co. Blew Drug Approval, Hurting Stocks
A Massachusetts biotech firm was sued Wednesday in New Jersey federal court by an investor who claimed the company's stock lost about a third of its value after regulators shelved an...To view the full article, register now.
Already a subscriber? Click here to view full article